Simplify Health Care ETF Rating → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free PINK Stock Alerts $29.31 -0.49 (-1.64%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsStock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings Simplify Health Care ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PINK Aggregate RatingModerate Buy2.66Holdings in PINK have an aggregate rating of Moderate Buy based on 529 analyst ratings issued in the past year covering 43 companies (100.0% of the portfolio).PINK Aggregate Price Target$35.5421.24% UpsideHigh Prediction$46.57Average Prediction$35.54Low Prediction$26.73Holdings in PINK have an aggregate price target of $35.54 and a range of $26.73 to $46.57 covering 43 companies (100.0% of the portfolio).PINK Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy28 Moderate Buy rating(s)Hold9 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 43 PINK Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings9.01%SRPTSarepta Therapeutics$132.58-2.5%4 of 5 stars2.79$160.60 21.1%14Insider SellingAnalyst Revision5.92%JNJJohnson & Johnson$148.95+0.2%5 of 5 stars2.46$175.86 18.1%13Analyst Forecast5.65%CIThe Cigna Group$347.31+0.2%5 of 5 stars2.92$366.14 5.4%13Earnings ReportAnalyst Revision5.54%CASHPathward Financial$53.99+0.2%3 of 5 stars2.50$63.00 16.7%2Insider Selling4.89%UNHUnitedHealth Group$503.21+0.4%5 of 5 stars2.83$570.05 13.3%184.87%MRKMerck & Co., Inc.$129.48-0.7%5 of 5 stars2.58$131.33 1.4%124.86%MMM3M$96.35+0.8%4 of 5 stars2.09$103.70 7.6%114.55%LLYEli Lilly and Company$775.00-0.4%5 of 5 stars2.84$757.95 -2.2%19Earnings ReportDividend Announcement4.38%COOCooper Companies$91.99-1.5%3 of 5 stars2.80$109.48 19.0%104.20%PCTPureCycle Technologies$4.77-5.0%2 of 5 stars2.20$7.75 62.5%5Gap Down4.01%MASIMasimo$120.02-11.8%5 of 5 stars2.43$138.71 15.6%7Earnings ReportAnalyst ForecastNews CoverageGap DownHigh Trading Volume3.72%BMRNBioMarin Pharmaceutical$81.83-0.9%5 of 5 stars2.63$107.50 31.4%19Insider Selling3.69%TMOThermo Fisher Scientific$573.64+0.1%5 of 5 stars2.71$607.35 5.9%173.58%BSXBoston Scientific$72.72-1.0%4 of 5 stars2.95$75.09 3.3%21Insider Selling3.38%HUMHumana$324.14-0.2%5 of 5 stars2.47$424.50 31.0%193.33%ISRGIntuitive Surgical$380.37-2.1%5 of 5 stars2.76$396.17 4.2%17Insider Selling2.54%REGNRegeneron Pharmaceuticals$955.76-1.5%4 of 5 stars2.70$981.71 2.7%202.41%ZBHZimmer Biomet$120.85-0.5%5 of 5 stars2.29$135.40 12.0%14Earnings ReportAnalyst Revision2.21%ELVElevance Health$533.35-0.5%5 of 5 stars2.92$587.42 10.1%13Positive News2.16%AVTRAvantor$24.27-2.3%5 of 5 stars2.75$26.71 10.1%162.07%RVTYRevvity$102.84-0.3%3 of 5 stars2.54$118.17 14.9%13Positive News1.34%SYKStryker$329.28-0.9%5 of 5 stars2.78$365.94 11.1%181.30%LPTXLeap Therapeutics$2.99-2.6%1 of 5 stars3.00$11.38 280.4%4Negative News1.24%RPRXRoyalty Pharma$27.99-1.0%5 of 5 stars3.00$46.75 67.0%4Positive News1.18%FULCFulcrum Therapeutics$7.59+0.7%2 of 5 stars2.83$13.17 73.5%6Upcoming Earnings1.05%RAREUltragenyx Pharmaceutical$41.56-1.0%4 of 5 stars2.92$87.85 111.4%12Earnings ReportAnalyst Forecast0.95%ASNDAscendis Pharma A/S$133.93-1.5%1 of 5 stars2.88$173.88 29.8%80.90%NTRANatera$95.66-1.5%2 of 5 stars3.00$86.40 -9.7%140.71%ABTAbbott Laboratories$104.94-1.2%5 of 5 stars2.67$121.50 15.8%9Insider Selling0.65%EXASExact Sciences$59.48-3.1%4 of 5 stars2.92$99.07 66.6%13News Coverage0.49%AKROAkero Therapeutics$21.02-4.5%3 of 5 stars2.86$37.71 79.4%7Gap Down0.49%ESTAEstablishment Labs$51.25-5.0%0 of 5 stars3.00$55.00 7.3%50.45%TECHBio-Techne$77.05-0.5%4 of 5 stars2.82$80.50 4.5%110.41%SNDXSyndax Pharmaceuticals$22.38-3.5%3 of 5 stars2.90$34.42 53.8%10News CoverageGap Down0.37%LIVNLivaNova$62.41-1.1%1 of 5 stars2.40$66.20 6.1%50.36%THCTenet Healthcare$122.86-1.0%4 of 5 stars3.00$113.19 -7.9%16Gap Up0.35%HCAHCA Healthcare$309.42-1.6%5 of 5 stars2.75$316.59 2.3%16Insider Selling0.30%VEEVVeeva Systems$201.74-1.7%5 of 5 stars2.65$234.90 16.4%20Positive News0.24%DHRDanaher$249.58+0.3%5 of 5 stars2.64$267.31 7.1%14Dividend Announcement0.20%HSICHenry Schein$72.76+2.2%4 of 5 stars2.36$81.09 11.4%11Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.03%VLTOVeralto$96.73-0.6%2 of 5 stars2.58$95.18 -1.6%12Positive News0.02%BMYBristol-Myers Squibb$43.67-0.8%5 of 5 stars2.11$60.00 37.4%190.01%EMBCEmbecta$10.27-2.7%4 of 5 stars1.50$16.00 55.8%2 This page (NYSEARCA:PINK) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithHow Biden has already won 2024Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market Insiders“Crash Insurance” For Your RetirementUnstoppable ProsperityThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
